These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 23933301)

  • 1. Involvement of substance P and the NK-1 receptor in cancer progression.
    Muñoz M; Coveñas R
    Peptides; 2013 Oct; 48():1-9. PubMed ID: 23933301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurokinin-1 receptor: a new promising target in the treatment of cancer.
    Muñoz M; Coveñas R
    Discov Med; 2010 Oct; 10(53):305-13. PubMed ID: 21034671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The substance P/neurokinin-1 receptor system in lung cancer: focus on the antitumor action of neurokinin-1 receptor antagonists.
    Muñoz M; González-Ortega A; Rosso M; Robles-Frias MJ; Carranza A; Salinas-Martín MV; Coveñas R
    Peptides; 2012 Dec; 38(2):318-25. PubMed ID: 23026680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The neurokinin-1 receptor antagonist aprepitant is a promising candidate for the treatment of breast cancer.
    Muñoz M; González-Ortega A; Salinas-Martín MV; Carranza A; Garcia-Recio S; Almendro V; Coveñas R
    Int J Oncol; 2014 Oct; 45(4):1658-72. PubMed ID: 25175857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NK-1 receptor antagonists as antitumor drugs: a survey of the literature from 2000 to 2011.
    Muñoz M; Martinez-Armesto J; Coveñas R
    Expert Opin Ther Pat; 2012 Jul; 22(7):735-46. PubMed ID: 22697287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer progression and substance P.
    Coveñas R; Muñoz M
    Histol Histopathol; 2014 Jul; 29(7):881-90. PubMed ID: 24535838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased expression of preprotachykinin-I and neurokinin receptors in human breast cancer cells: implications for bone marrow metastasis.
    Singh D; Joshi DD; Hameed M; Qian J; Gascón P; Maloof PB; Mosenthal A; Rameshwar P
    Proc Natl Acad Sci U S A; 2000 Jan; 97(1):388-93. PubMed ID: 10618428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of substance P and the NK-1 receptor in pancreatic cancer.
    Muñoz M; Coveñas R
    World J Gastroenterol; 2014 Mar; 20(9):2321-34. PubMed ID: 24605029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles of full-length and truncated neurokinin-1 receptors on tumor progression and distant metastasis in human breast cancer.
    Zhou Y; Zhao L; Xiong T; Chen X; Zhang Y; Yu M; Yang J; Yao Z
    Breast Cancer Res Treat; 2013 Jul; 140(1):49-61. PubMed ID: 23807418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uveal melanoma expresses NK-1 receptors and cyclosporin A induces apoptosis in human melanoma cell lines overexpressing the NK-1 receptor.
    González-Ortega A; Sánchez-Vaderrábanos E; Ramiro-Fuentes S; Salinas-Martín MV; Carranza A; Coveñas R; Muñoz M
    Peptides; 2014 May; 55():1-12. PubMed ID: 24548567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Airway smooth muscle cells express functional neurokinin-1 receptors and the nerve-derived preprotachykinin-a gene: regulation by passive sensitization.
    Maghni K; Michoud MC; Alles M; Rubin A; Govindaraju V; Meloche C; Martin JG
    Am J Respir Cell Mol Biol; 2003 Jan; 28(1):103-10. PubMed ID: 12495938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The NK-1 receptor: a new target in cancer therapy.
    Muñoz M; Rosso M; Coveñas R
    Curr Drug Targets; 2011 Jun; 12(6):909-21. PubMed ID: 21226668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substance P autocrine signaling contributes to persistent HER2 activation that drives malignant progression and drug resistance in breast cancer.
    Garcia-Recio S; Fuster G; Fernandez-Nogueira P; Pastor-Arroyo EM; Park SY; Mayordomo C; Ametller E; Mancino M; Gonzalez-Farre X; Russnes HG; Engel P; Costamagna D; Fernandez PL; Gascón P; Almendro V
    Cancer Res; 2013 Nov; 73(21):6424-34. PubMed ID: 24030979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The broad-spectrum antitumor action of cyclosporin A is due to its tachykinin receptor antagonist pharmacological profile.
    Muñoz M; Rosso M; González A; Saenz J; Coveñas R
    Peptides; 2010 Sep; 31(9):1643-8. PubMed ID: 20542069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory cells as source of tachykinin-induced mucus secretion in chronic bronchitis.
    Springer J; Groneberg DA; Pregla R; Fischer A
    Regul Pept; 2005 Jan; 124(1-3):195-201. PubMed ID: 15544859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatoblastoma cells express truncated neurokinin-1 receptor and can be growth inhibited by aprepitant in vitro and in vivo.
    Berger M; Neth O; Ilmer M; Garnier A; Salinas-Martín MV; de Agustín Asencio JC; von Schweinitz D; Kappler R; Muñoz M
    J Hepatol; 2014 May; 60(5):985-94. PubMed ID: 24412605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antiproliferative action of [D-Arg(1), D-Phe(5), D-Trp(7,9), LEU(11)] substance P analogue antagonist against small-cell- and non-small-cell lung cancer cells could be due to the pharmacological profile of its tachykinin receptor antagonist.
    Munoz M; Recio S; Rosso M; Redondo M; Covenas R
    J Physiol Pharmacol; 2015 Jun; 66(3):421-6. PubMed ID: 26084224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neonatal capsaicin treatment affects rat thymocyte proliferation and cell death by modulating substance P and neurokinin-1 receptor expression.
    Santoni G; Amantini C; Lucciarini R; Perfumi M; Pompei P; Piccoli M
    Neuroimmunomodulation; 2004; 11(3):160-72. PubMed ID: 15067207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of substance P and its neurokinin-1 receptor on thymocytes: functional relevance in the regulation of thymocyte apoptosis and proliferation.
    Santoni G; Amantini C; Lucciarini R; Pompei P; Perfumi M; Nabissi M; Morrone S; Piccoli M
    Neuroimmunomodulation; 2002-2003; 10(4):232-46. PubMed ID: 12584411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurotransmitter substance P mediates pancreatic cancer perineural invasion via NK-1R in cancer cells.
    Li X; Ma G; Ma Q; Li W; Liu J; Han L; Duan W; Xu Q; Liu H; Wang Z; Sun Q; Wang F; Wu E
    Mol Cancer Res; 2013 Mar; 11(3):294-302. PubMed ID: 23345604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.